Relmada Therapeutics has acquired complete worldwide ownership rights to Sepranolone from Sweden-based Asarina Pharma.

Relmada Therapeutics is a clinical-stage biotechnology company focused on developing innovative therapies for central nervous system (CNS) and metabolic disorders. With a commitment to advancing ...

Baylen Out Loud star Baylen Dupree is taking a major step with boyfriend Colin Dooley. The 22-year-old influencer was ...

The following is a summary of “Randomized Controlled Trial of the Effects of High-Dose Ondansetron on Clinical Symptoms and Brain Connectivity in Obsessive-Compulsive and Tic Disorders,” published in ...

Low-quality information on social media may be contributing to a rise in teen mental illness. A new construct may help ...

Tourette syndrome is currently diagnosed about three times more frequently in males than in females. A new study finds that female individuals are less likely to be diagnosed with the syndrome, take ...

CORAL GABLES, Fla. - Relmada Therapeutics , Inc. (NASDAQ:RLMD), a clinical-stage biotechnology firm with a market capitalization of $11.5 million, has announced the acquisition of Sepranolone, a Phase ...

In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on an acquisition, study results ...

After revealing she was in remission from MS in 2021, the actor is sharing a glimpse into life with the condition.

However, we still see areas of weakness in the portfolio, including upcoming patent losses and a highly uncertain pipeline due to the complexities of running CNS trials. Historically, the firm ...

As the sun appeared on the horizon on Wednesday, so too did the House’s version of the Amended FY 2025 State Budget. Synchronized perfectly ...

There's a big stigma surrounding Tourette syndrome and other brain disorders, but Milan teacher Larry Biederman is working to break ...